Table 2. Operative and post-operative characteristics (n = 340)

Characteristics Median (Q1-Q3)/Number (%)
Operative time (minutes) 150 (120 – 180)
Blood loss (mL) 150 (100 – 200)
Hospital stay (days) 8 (7 – 10)
Hepatectomy
 Major (≥4 segments) 137 (40.3)
 Minor (< 4 segments) 203 (59.7)
Morbidity
 No 268 (78.8)
 PHLF 42 (12.4)
 Other 30 (8.8)
PHLF
 No 298 (87.6)
 Grade A 30 (8.8)
 Grade B 10 (2.9)
 Grade C 2 (0.6)
Death 3 (0.9)
Tumor nature
 HCC 270 (79.4)
 Necrotic tissue (after TACE) 2 (0.6)
 CCC 29 (8.5)
 HCC + CCC 1 (0.3)
 Liver metastasis 14 (4.0)
 Neuroendocrine tumor 1 (0.3)
 Benign tumor 14 (4.0)
 Normal liver parenchyma (liver donation) 9 (2.7)
Histological fibrosis stage (Ishak score)
 0/6 112 (32.9)
 1/6 53 (15.6)
 2/6 33 (9.7)
 3/6 54 (15.9)
 4/6 46 (13.5)
 5/6 36 (10.6)
 6/6 6 (1.8)
PHLF: post-hepatectomy liver failure. HCC: hepatocellular carcinoma. CCC: cholangiocellular carcinoma. TACE: transcatheter arterial chemoembolization. Other morbidity included biliary fistula, ascites, fluid collection, biliary stenosis, intraoperative biliary injury, pneumonia, acute renal injury, myocardial infraction